Resmed Inc. buy UBS Group AG
Start price
20.09.25
/
50%
€234.30
Target price
20.09.26
-
Performance (%)
-17.09%
Price
18:06
€194.25
Summary
This prediction is currently active. The prediction for Resmed Inc. disappoints with a performance of -17.09%. This prediction currently runs until 20.09.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -2.154% | -2.154% |
| iShares Core DAX® | 0.789% | 1.975% |
| iShares Nasdaq 100 | 4.226% | 4.344% |
| iShares Nikkei 225® | 3.285% | 6.991% |
| iShares S&P 500 | 2.496% | 2.759% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Ratings data for RMD provided by MarketBeat